https://www.selleckchem.com/pr....oducts/ozanimod-rpc1
To determine the effectiveness of liquid human milk fortifiers (HMFs) derived from exclusive HM or hydrolyzed protein on growth, necrotizing enterocolitis (NEC), or late-onset sepsis in North American very low-birth-weight (VLBW) infants compared with powder HMFs (control). Prospective trials published between 2009 and 2020 were systematically reviewed, and meta-analysis was conducted by using a random-effects model. Five studies were identified for up to 591 participants across 39 centers. Study treatments included whey or cas
Aimer
Commentaire
Partagez
